Dr. Richard Faris, PhD, MSc, RPh, will bring his extensive expertise to NASP, helping to guide the organization as it advances specialty pharmacy, promotes innovation, and strengthens patient care and support services. His leadership at PANTHERx, where he drives initiatives to deliver personalized support and improve outcomes for patients with rare and complex conditions, aligns closely with NASP’s mission to ensure all patients have access to life-saving medications and the high-touch care they need.
Dr. Richard Faris, Chief Commercial & Clinical Officer at PANTHERx Rare, elected to the Board of Directors for the National Association of Specialty Pharmacy (NASP)
GlobeNewswire |